BDX

Becton, Dickinson and Company (NYSE:BDX) is a leading global medical technology company founded in 1897 and headquartered in Franklin Lakes, New Jersey. The company has evolved from its origins as a thermometer manufacturer into one of the world's largest medical device and diagnostics companies, serving healthcare institutions, life science researchers, clinical laboratories, and pharmaceutical companies worldwide. BD went public in 1973 and has maintained a strong dividend track record, with 53 consecutive years of dividend increases as of 2024. The company is currently undergoing a strategic transformation, having announced plans to separate its Biosciences and Diagnostic Solutions business to create a more focused pure-play medical technology company.